Caxton Associates (UK)’s Cytek Biosciences CTKB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$352K Buy
103,465
+1,571
+2% +$5.34K 0.01% 507
2025
Q1
$409K Buy
+101,894
New +$409K 0.01% 541